Differential protein analysis of lymphocytes between children with acute lymphoblastic leukemia and healthy children

References

• Miron I, Ivanov A, Ivanov I, . Detection of fusion gene--integral part of the assessment of children with acute leukemia. Rev Med Chir Soc Med Nat Iasi 2011;115:731–735.
   PubMedGoogle Scholar
• Harrison CJ. Acute lymphoblastic leukemia. Clin Lab Med 2011; 31:631–647.
   PubMed Web of Science ®Google Scholar
• Kwiecińska K, Balwierz W, Moryl-Bujakowska A, . long-term observations of children with acute lymphoblastic leukemia and high leukocytosis treated according to modified “New York” protocols (1987–2003). Przegl Lek 2010;67:350–354.
   PubMedGoogle Scholar
• Li G, Xiao Z, Liu J, . Cancer: a proteomic disease. Sci China Life Sci 2011;54:403–408.
   PubMed Web of Science ®Google Scholar
• Banks RE, Dunn MJ, Hochstrasser DF, . Proteomics: new perspectives, new biomedical opportunities. Lancet 2000;356: 1749–1756.
   PubMed Web of Science ®Google Scholar
• Blueggel M, Chamrad D, Meyer HE. Bioinformatics in proteomics. Curr Pharm Biotechnol 2004;5:79–88.
   PubMed Web of Science ®Google Scholar
• Hoeben A, Landuyt B, Botrus G, . Proteomics in cancer research: methods and application of array-based protein profiling technologies. Anal Chim Acta 2006;564:19–33.
   PubMed Web of Science ®Google Scholar
• Caprioli RM, Farmer TB, Gile J. Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS. Anal Chem 1997;69:4751–4760.
   PubMed Web of Science ®Google Scholar
• Chaurand P, Schwartz SA, Caprioli RM. Imaging mass spectrometry: a new tool to investigate the spatial organization of peptides and proteins in mammalian tissue sections. Curr Opin Chem Biol 2002;6:676–681.
   PubMed Web of Science ®Google Scholar
• McDonnell LA, Corthals GL, Willems SM, . Peptide and protein imaging mass spectrometry in cancer research. J Proteomics 2010;73:1921–1944.
   PubMed Web of Science ®Google Scholar
• Burns P, Armitage JO, Frey AL, . Analysis of the presenting features of adult acute leukemias:the French–American–British classification. Cancer 1981;47:2460–2469.
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, . Protein measurement with folin phenol reagent. J Biol Chem 1951;193:265–275.
   PubMed Web of Science ®Google Scholar
• Görg A, Obermaier C, Boguth G, . The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 2000;21:1037–1053.
   PubMed Web of Science ®Google Scholar
• Farias-Eisner R, Reddy ST. Biomarkers for early detection of ovarian cancer. US Patent 2010;7:670–792.
   Google Scholar
• Hayashi N, Kuruma H, Egawa S. New marker proteins for prostate cancer. Nihon Rinsho 2011;69:140–144.
   PubMedGoogle Scholar
• Barderas R, Babel I, Casal JI. Colorectal cancer proteomics, molecular characterization and biomarker discovery. Proteomics Clin Appl 2010;4:159–178.
   PubMed Web of Science ®Google Scholar
• Whitbread AK, Masoumi A, Tetlow N, . Characterization of the omega class of glutathione transferases. Methods Enzymol 2005;401:78–99.
   PubMed Web of Science ®Google Scholar
• He S, Liao TT, Chen YT, . Glutathione-S-transferase enhances proliferation-migration and protects against shikonin-induced cell death in breast cancer cells. Kaohsiung J Med Sci 2011; 27:477–484.
   PubMed Web of Science ®Google Scholar
• Wang Z, He W, Yang G, . Decreased expression of GST pi is correlated with a poor prognosis in human esophageal squamous carcinoma. BMC Cancer 2010;10:352.
   PubMed Web of Science ®Google Scholar
• Saip R, Sen F, Vural B, . Glutathione S-transferase P1 polymorphisms are associated with time to tumor progression in small cell lung cancer patients. J BUON 2011;16:241–246.
   PubMed Web of Science ®Google Scholar
• Ho T, Zhao C, Zheng R, . Glutathione S-transferase polymorphisms and risk of differentiated thyroid carcinomas: a case-control analysis. Arch Otolaryngol Head Neck Surg 2006;132:756–761.
   PubMed Web of Science ®Google Scholar
• Pasello M, Michelacci F, Scionti I, . Overcoming glutathione S-transferase P1-related cisplatin resistance in osteosarcoma. Cancer Res 2008;68:6661–6668.
   PubMed Web of Science ®Google Scholar
• Bryzgunova OE, Morozkin ES, Yarmoschuk SV, . Methylation-specific sequencing of GSTP1 gene promoter in circulating/ extracellular DNA from blood and urine of healthy donors and prostate cancer patients. Ann NY Acad Sci 2008;1137:222–225.
   PubMed Web of Science ®Google Scholar
• Sutoh I, Kohno H, Nakashima Y, . Concurrent expressions of metallothionein, glutathione S-transferase-pi, and P-glycoprotein in colorectal cancers. Dis Colon Rectum 2000;43:221–232.
   PubMed Web of Science ®Google Scholar
• Den Boer ML, Pieters R, Kazemier KM, . Different expression of glutathione S-transferase alpha, mu and pi in childhood acute lymphoblastic and myeloid leukaemia. Br J Haematol 1999;104:321–327.
   PubMed Web of Science ®Google Scholar
• Krajinovic M, Labuda D, Sinnett D. Glutathione S-transferase P1 genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukaemia. Pharmacogenetics 2002;12:655–658.
   PubMedGoogle Scholar
• Xu Z, Wu J, Zha X. Up-regulation of prohibitin 1 is involved in the proliferation and migration of liver cancer cells. Sci China Life Sci 2011;54:121–127.
   PubMed Web of Science ®Google Scholar
• Wong PF, Cheong WF, Shu MH, . Eurycomanone suppresses expression of lung cancer cell tumor markers, prohibitin, annexin 1 and endoplasmic reticulum protein 28. Phytomedicine 2012;19:138–144.
   PubMed Web of Science ®Google Scholar
• Jia L, Yi XF, Zhang ZB, . Prohibitin as a novel target protein of luteinizing hormone in ovarian epithelial carcinogenesis. Neoplasma 2011;58:104–109.
   PubMed Web of Science ®Google Scholar
• Chen D, Chen F, Lu X, . Identification of prohibitin as a potential biomarker for colorectal carcinoma based on proteomics technology. Int J Oncol 2010;37:355–365.
   PubMed Web of Science ®Google Scholar
• Basu A, Banerjee H, Rojas H, . Differential expression of peroxiredoxins in prostate cancer: consistent upregulation of PRDX3 and PRDX4. Prostate 2011;71:755–765.
   PubMed Web of Science ®Google Scholar
• Li M, Lin YM, Hasegawa S, . Genes associated with liver metastasis of colon cancer, identified by genome-wide cDNA microarray. Int J Oncol 2004;24:305–312.
   PubMed Web of Science ®Google Scholar
• Palande KK, Beekman R, van der Meeren LE, . The antioxidant protein peroxiredoxin 4 is epigenetically down regulated in acute promyelocytic leukemia. PLoS One 2011;6:e16340.
   Web of Science ®Google Scholar
• Jang JS, Cho HY, Lee YJ, . The differential proteome profile of stomach cancer: identification of the biomarker candidates. Oncol Res 2004;14:491–499.
   PubMed Web of Science ®Google Scholar
• Jin DY, Chae HZ, Rhee SG, . Regulatory role for a novel human thioredoxin peroxidase in NF-kappaB activation. J Biol Chem 1997;272:30952–30961.
   PubMed Web of Science ®Google Scholar
• Chang TW, Chen CC, Chen KY, . Ribosomal phosphoprotein P0 interacts with GCIP and overexpression of P0 is associated with cellular proliferation in breast and liver carcinoma cells. Oncogene 2008;27:332–338.
   PubMed Web of Science ®Google Scholar
• Chen Y, Lin MC, Wang H, . Proteomic analysis of EZH2 downstream target proteins in hepatocellular carcinoma. Proteomics 2007;7:3097–3104.
   PubMed Web of Science ®Google Scholar
• Schmitt-Gräff A, Chaponnier C, Gabbiani G. Cytoskeletal organization of peripheral blood normal and leukemic lymphocytes and lymphoblasts. J Submicrosc Cytol 1987;19:329–335.
   PubMedGoogle Scholar
• Valera VA, Li-Ning T E, Walter BA, . Protein expression profiling in the spectrum of renal cell carcinomas. J Cancer 2010;1: 184–196.
   PubMed Web of Science ®Google Scholar
• Zhang XZ, Xiao ZF, Li C, . Triosephosphate isomerase and peroxiredoxin 6, two novel serum markers for human lung squamous cell carcinoma. Cancer Sci 2009;100:2396–2401.
   PubMed Web of Science ®Google Scholar